PREVIEW

Trump Unveils IVF Policies but Offers No New Funding or Coverage Mandates. President Donald Trump announced two new policies aimed at improving access to in-vitro fertilization (IVF) — one lowering the cost of a key fertility drug and another encouraging employers to expand fertility benefits. Speaking from the Oval Office, Trump said the goal was to “make it easier for all couples to have babies and the families they have always dreamed about.” The initiatives fulfill a campaign promise to support fertility care but include no new federal funding or insurance coverage requirements for IVF, which can cost up to $20,000 per cycle. The price of EMD Serono’s Gonal-F, a hormone injection used during IVF, will drop by 42–79% depending on income, with discounts available early next year through TrumpRx, a forthcoming White House drug-discount platform. CVS and Express Scripts, which distribute most of the drug’s supply, agreed to reduce associated handling costs, the administration said. New guidance will also allow employers to offer standalone fertility benefits outside of traditional health insurance plans, similar to dental or vision coverage — but participation will be voluntary. The FDA will fast-track approval of EMD Serono’s new fertility drug, Pergoveris, as part of a pilot program to speed up review times and boost competition. Trump’s IVF push has won support from pro-natalist conservatives but angered anti-abortion activists with Live Action’s Lila Rose calling IVF “not a solution” and claiming it “kills more babies than abortion.”
Instructions: THIS VIDEO MUST NOT BE EDITED FOR LENGTH TO COMBINE WITH OTHER CONTENT